FNY Investment Advisers’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

FNY Investment Advisers’s Portfolio TLC Stock Details TLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,233	Closed	-$36K	–	1029
2021 Q2	$36K	Buy	+6,233	New	+$35.7K	0.01%	481

FNY Investment Advisers's TLC Position: Q3 2021 in Review

FNY Investment Advisers sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q3 2021, closing a stake of 6,233 shares — an estimated $36K sold.

FNY Investment Advisers first reported a position in TLC in Q2 2021 and held it in 1 quarter. The position peaked at $36K in Q2 2021. 0 funds tracked by Wall St. Rank hold TLC as of Q3 2021.

FNY Investment Advisers reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q3 2021 after selling out during the quarter.
FNY Investment Advisers sold 6,233 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q3 2021, an estimated $36K.
FNY Investment Advisers first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q2 2021 and held it in 1 quarter.
FNY Investment Advisers's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $36K in Q2 2021.
0 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q3 2021.

Based on FNY Investment Advisers's 13F filing for Q3 2021, filed 13 Oct 2021.